We report a case of pustular psoriasis induced by anti-TNF-α therapy in a 12-year-old boy with inflammatory bowel disease. This is a well-documented phenomenon but remains a clinical challenge, especially when presenting in the pediatric setting.

Vemurafenib is increasingly being used to treat nonmelanoma tumors that are positive for the BRAF V600E mutation. We report three children who presented with panniculitis induced by vemurafenib while undergoing treatment for central nervous system tumors and review the literature.